TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group

The tet oncogene family member 2 (TET2) gene was recently identified to be mutated in myeloid disorders including acute myeloid leukemia (AML). To date, there is increasing evidence for a functional role of TET2 mutations (TET2(mut)) in AML. Thus, we explored the frequency, gene-expression pattern,...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 30; no. 12; pp. 1350 - 1357
Main Authors GAIDZIK, Verena I, PASCHKA, Peter, BENTZ, Martin, GÖTZE, Katharina, DÖHNER, Hartmut, SCHLENK, Richard F, BULLINGER, Lars, DÖHNER, Konstanze, SPÄTH, Daniela, HABDANK, Marianne, KÖHNE, Claus-Henning, GERMING, Ulrich, VON LILIENFELD-TOAL, Marie, HELD, Gerhard, HORST, Heinz-August, HAASE, Detlef
Format Journal Article
LanguageEnglish
Published Alexandria, VA American Society of Clinical Oncology 20.04.2012
Subjects
Online AccessGet full text

Cover

Loading…